NO306407B1 - Kompleks, fremgangsmaate for dannelse derav, radioaktivt merket makromolekyl og anvendelse av ligand med formel L - Google Patents

Kompleks, fremgangsmaate for dannelse derav, radioaktivt merket makromolekyl og anvendelse av ligand med formel L

Info

Publication number
NO306407B1
NO306407B1 NO931585A NO931585A NO306407B1 NO 306407 B1 NO306407 B1 NO 306407B1 NO 931585 A NO931585 A NO 931585A NO 931585 A NO931585 A NO 931585A NO 306407 B1 NO306407 B1 NO 306407B1
Authority
NO
Norway
Prior art keywords
ligand
hydroxyalkyl
complex
formation
formula
Prior art date
Application number
NO931585A
Other languages
English (en)
Norwegian (no)
Other versions
NO931585D0 (no
NO931585L (no
Inventor
Gary James Bridger
Pedro Emilio Hernandez
Iii John David Higgins
Scott Kenneth Larsen
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc filed Critical Anormed Inc
Publication of NO931585D0 publication Critical patent/NO931585D0/no
Publication of NO931585L publication Critical patent/NO931585L/no
Publication of NO306407B1 publication Critical patent/NO306407B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0476—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Confectionery (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Road Signs Or Road Markings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Casings For Electric Apparatus (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO931585A 1992-05-02 1993-04-30 Kompleks, fremgangsmaate for dannelse derav, radioaktivt merket makromolekyl og anvendelse av ligand med formel L NO306407B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209641A GB9209641D0 (en) 1992-05-02 1992-05-02 Improvements in radiolabelling

Publications (3)

Publication Number Publication Date
NO931585D0 NO931585D0 (no) 1993-04-30
NO931585L NO931585L (no) 1993-11-03
NO306407B1 true NO306407B1 (no) 1999-11-01

Family

ID=10714995

Family Applications (1)

Application Number Title Priority Date Filing Date
NO931585A NO306407B1 (no) 1992-05-02 1993-04-30 Kompleks, fremgangsmaate for dannelse derav, radioaktivt merket makromolekyl og anvendelse av ligand med formel L

Country Status (18)

Country Link
US (1) US5350837A (de)
EP (1) EP0569132B1 (de)
JP (1) JP3271259B2 (de)
KR (1) KR100293777B1 (de)
AT (1) ATE190063T1 (de)
AU (1) AU663581B2 (de)
CA (1) CA2094380C (de)
DE (1) DE69327914T2 (de)
DK (1) DK0569132T3 (de)
ES (1) ES2143489T3 (de)
FI (1) FI931968L (de)
GB (1) GB9209641D0 (de)
GR (1) GR3033379T3 (de)
NO (1) NO306407B1 (de)
NZ (1) NZ247445A (de)
PT (1) PT569132E (de)
TW (1) TW227564B (de)
ZA (1) ZA932844B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
US5744120A (en) 1993-03-30 1998-04-28 The Dupont Merick Pharmaceutical Company Ternary radiopharmaceutical complexes
US5480970A (en) * 1993-12-22 1996-01-02 Resolution Pharmaceuticals Metal chelators
US5569745A (en) * 1994-02-25 1996-10-29 Resolution Pharmaceuticals Inc. Peptide-Chelator conjugates
ZA955642B (en) * 1994-07-07 1997-05-06 Ortho Pharma Corp Lyophilized imaging agent formulation
US5662885A (en) * 1994-07-22 1997-09-02 Resolution Pharmaceuticals Inc. Peptide derived radionuclide chelators
US5942210A (en) * 1994-11-15 1999-08-24 Cytogen Corporation Methods for lyoprotecting a macromolecule using tricine
EP0888130B1 (de) * 1996-03-13 2003-07-02 Bristol-Myers Squibb Pharma Company Ternäre radiopharmazeutische komplexe
US5879659A (en) * 1996-03-13 1999-03-09 Dupont Pharmaceuticals Company Ternary radiopharmaceutical complexes
US6416733B1 (en) * 1996-10-07 2002-07-09 Bristol-Myers Squibb Pharma Company Radiopharmaceuticals for imaging infection and inflammation
US20030124053A1 (en) * 1996-10-07 2003-07-03 Barrett John Andrew Radiopharmaceuticals for imaging infection and inflammation
US6403054B1 (en) 1997-05-28 2002-06-11 Bristol-Myers Squibb Pharma Company Ternary ligand complexes useful as radiopharmaceuticals
US6524553B2 (en) 1998-03-31 2003-02-25 Bristol-Myers Squibb Pharma Company Quinolone vitronectin receptor antagonist pharmaceuticals
US6548663B1 (en) 1998-03-31 2003-04-15 Bristol-Myers Squibb Pharma Company Benzodiazepine vitronectin receptor antagonist pharmaceuticals
US6537520B1 (en) * 1998-03-31 2003-03-25 Bristol-Myers Squibb Pharma Company Pharmaceuticals for the imaging of angiogenic disorders
AU3119199A (en) 1998-04-03 1999-10-25 Du Pont Pharmaceuticals Company Radiopharmaceuticals for imaging infection and inflammation and for imaging and treatment of cancer
CA2349501A1 (en) 1998-12-18 2000-06-22 Du Pont Pharmaceuticals Company Quinolone vitronectin receptor antagonist pharmaceuticals
US6511649B1 (en) * 1998-12-18 2003-01-28 Thomas D. Harris Vitronectin receptor antagonist pharmaceuticals
EP1140864A2 (de) * 1998-12-18 2001-10-10 Du Pont Pharmaceuticals Company Pharmazeutische zusammensetzungen, vitronectinrezeptor antagonisten enthaltend
US6569402B1 (en) 1998-12-18 2003-05-27 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
US6794518B1 (en) * 1998-12-18 2004-09-21 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
EP1153010A1 (de) * 1999-02-08 2001-11-14 Checkpoint Genetics, Inc. N-substituierte aminosäuren, pharmazeutische antioxidant-zusammensetzungen die diese enthalten und verfahren zu ihrer anwendung
US6808698B1 (en) 1999-03-26 2004-10-26 Bristol-Myers Squibb Pharma Company Method for localization of blood clots
US6534038B2 (en) 2000-04-07 2003-03-18 Bristol-Myers Squibb Pharma Company Ternary ligand complexes useful as radiopharmaceuticals
HUP0400758A3 (en) 2000-11-03 2005-02-28 Bristol Myers Squibb Pharma Co Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
US6517814B2 (en) 2001-01-09 2003-02-11 Bristol-Myers Squibb Pharma Company Macrocyclic chelants useful for metallopharmaceuticals
US6776977B2 (en) 2001-01-09 2004-08-17 Bristol-Myers Squibb Pharma Company Polypodal chelants for metallopharmaceuticals
MXPA04001113A (es) * 2001-08-08 2004-07-08 Bristol Myers Squibb Pharma Co Formacion de imagenes simultaneas de perfusion cardiaca y agente formador de imagenes dirigido al receptor de vitronectina.
US6838074B2 (en) 2001-08-08 2005-01-04 Bristol-Myers Squibb Company Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
US7319149B2 (en) * 2003-06-13 2008-01-15 Bristol-Myers Squibb Pharma Company Chelants and macrocyclic metal complex radiopharmaceuticals thereof
US7317104B2 (en) 2003-06-13 2008-01-08 Bristol-Myers Squibb Pharma Company Chelants and macrocyclic metal complex radiopharmaceuticals thereof
US20050106100A1 (en) * 2003-09-03 2005-05-19 Harris Thomas D. Compounds containing matrix metalloproteinase substrates and methods of their use
KR20080022588A (ko) * 2005-06-30 2008-03-11 브리스톨-마이어스 스퀴브 파마 컴퍼니 영상화제로서의 히드라지드 컨쥬게이트
US7635791B2 (en) * 2008-04-17 2009-12-22 Tpat Ip Llc Biological buffers with wide buffering ranges
US9090638B2 (en) 2008-04-17 2015-07-28 Thomas Daly Biological buffers with wide buffering ranges
US8034951B2 (en) * 2008-04-17 2011-10-11 Thomas Daly Biological buffers with wide buffering ranges
US9447310B2 (en) 2008-04-17 2016-09-20 Thomas P. Daly Biological buffers with wide buffering ranges
US8519141B2 (en) 2008-04-17 2013-08-27 Thomas Daly Biological buffers with wide buffering ranges
US8334402B2 (en) 2008-04-17 2012-12-18 Thomas Daly Biological buffers with wide buffering ranges
US7939659B2 (en) * 2008-04-17 2011-05-10 Thomas Daly Biological buffers with wide buffering ranges
US8822728B2 (en) 2008-04-17 2014-09-02 Thomas Daly Biological buffers with wide buffering ranges
US20170313920A1 (en) 2010-10-06 2017-11-02 Thomas P. Daly Biological Buffers with Wide Buffering Ranges
US9475754B2 (en) 2011-10-06 2016-10-25 Thomas P. Daly Biological buffers with wide buffering ranges

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7504915L (sv) * 1974-04-30 1975-10-31 Solco Basel Ag Medel for att diagnostiskt synliggora neoplastiska vevnader.
US4017596A (en) * 1975-03-03 1977-04-12 Research Corporation Radiopharmaceutical chelates and method of external imaging
US4425280A (en) * 1981-03-30 1984-01-10 Ferro Corporation Metal amino acids
US4772724A (en) * 1986-12-02 1988-09-20 Warner-Lambert Canada Inc. Essentially pure acid hydroxyl ligand aluminum complexes and their preparation
DE3855239T2 (de) * 1987-07-16 1996-10-31 Nycomed Imaging As Aminocarbonsäure und Derivate
IL93432A (en) * 1989-02-24 1994-02-27 Johnson Mathey Inc Hydrazines and hydrazides, their conjugates with macromolecules and such conjugates labelled with metal ions

Also Published As

Publication number Publication date
ES2143489T3 (es) 2000-05-16
KR100293777B1 (ko) 2001-11-22
FI931968A0 (fi) 1993-04-30
FI931968A7 (fi) 1993-11-03
CA2094380C (en) 2002-02-12
ZA932844B (en) 1994-06-21
ATE190063T1 (de) 2000-03-15
JP3271259B2 (ja) 2002-04-02
EP0569132A1 (de) 1993-11-10
DE69327914D1 (de) 2000-04-06
EP0569132B1 (de) 2000-03-01
NO931585D0 (no) 1993-04-30
HK1013828A1 (en) 1999-09-10
AU3717393A (en) 1993-11-04
KR930023028A (ko) 1993-12-18
FI931968L (fi) 1993-11-03
JPH0665169A (ja) 1994-03-08
NO931585L (no) 1993-11-03
GB9209641D0 (en) 1992-06-17
PT569132E (pt) 2000-08-31
DK0569132T3 (da) 2000-07-31
GR3033379T3 (en) 2000-09-29
CA2094380A1 (en) 1993-11-03
DE69327914T2 (de) 2000-06-29
TW227564B (de) 1994-08-01
US5350837A (en) 1994-09-27
AU663581B2 (en) 1995-10-12
NZ247445A (en) 1995-07-26

Similar Documents

Publication Publication Date Title
FI931968A0 (fi) Foerbaettringar i radiostaempling
EP0446071A3 (en) Tris-maleimido compounds as intermediates in trifunctional antibody synthesis
UA29494C2 (uk) Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція
IT8320550A0 (it) Procedimento di purificazione peraffinita' in cui si impiegano anticorpi monoclonali.
DE3686313D1 (de) Anti-immuntoxine gegen menschlichen eierstockkrebs und verfahren zu deren verwendung.
FR2344055A1 (fr) Unite de filtration pour l'elimination de vapeurs toxiques, en particulier de vapeurs ammoniacales
SE8704204D0 (sv) Substituted alfa-aminoacids, their preparation and pharmaceutical compositions containing them
PT922700E (pt) Quelatos metalicos de derivados macrociclicos poliaminocarboxilicos e sua aplicacao em formacao de imagem para diagnostico
DE69127487D1 (de) Verfahren zum Nachweis der Alzheimer-Krankheit
FR2551635B1 (fr) Element accessoire pour poussoir d'articles tels que boucles, fermoirs et moraillons
BG42184A3 (bg) Метод за скатаване на чували
PT74470A (de) Chemische verbindungen verfahren zu ihrer herstellung und ihre verwendungen als antigene oder immunadsorbentien
ES264189Y (es) "disposicion de cierre de cremallera".
BE843818A (fr) Pieces d'usure pour recipients contenant du metal fondu
FR2657035B1 (fr) Machine pour l'affutage de forets helicouidaux.
IL96153A0 (en) Synthesis of perfluoroalkyl bromides
ATE190053T1 (de) Aromatische aminsubstituierte liganden mit verbrückten stickstoff-und schwefeldonatoratomen für bildformung
FR2645091B1 (fr) Perfectionnement aux dispositifs formant joints d'etancheite pour vitres coulissantes de vehicules
IT7821611A0 (it) Dispositivo per l'applicazione di guarnizioni di tenuta in profilati di minuteria metallica.
FR2352875A1 (fr) Composition d'huiles minerales amelioree
BE872173A (fr) Dispositif palpeur a faisceau lumineux pour piloter les axes des outils d'une machine a copier a partir d'un profil
FR2696815B1 (fr) Engin pour inspection visuelle de branchements d'une canalisation.
ES262499Y (es) "disposicion de fondos cerrados de bolsas reticulares".
FR2511773B1 (fr) Procede de diagraphie pour l'etude geologique des formations souterraines
IT8085587A0 (it) Dispositivo di chiusura pergravita' delle fessure sotto le porte.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees